BHB
RDHL

Bank Hapoalim BM’s Redhill Biopharma RDHL Stock Holding History

Bank Hapoalim BM’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-136
Closed -$1.47M – 217
2017
Q3 		$1.47M Sell
136
-40
-23% -$356K 0.33% 62
2017
Q2 		$1.51M Sell
176
-4
-2% -$38.5K 0.36% 57
2017
Q1 		$1.73M Sell
180
-14
-7% -$140K 0.41% 55
2016
Q4 		$2.03M Buy
194
+46
+31% +$551K 0.54% 43
2016
Q3 		$2.05M Buy
148
+102
+222% +$1.43M 0.48% 46
2016
Q2 		$498K Hold
46
– – 0.12% 119
2016
Q1 		$561K Sell
46
-9
-16% -$94.2K 0.13% 102
2015
Q4 		$709K Sell
55
-18
-25% -$224K 0.16% 90
2015
Q3 		$937K Buy
73
+20
+38% +$296K 0.22% 79
2015
Q2 		$928K Buy
53
+30
+130% +$476K 0.18% 92
2015
Q1 		$337K Buy
+23
New +$327K 0.06% 131

Other funds holding RDHL

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Bank Hapoalim BM's RDHL Position: Q4 2017 in Review

Bank Hapoalim BM sold out of Redhill Biopharma (RDHL) in Q4 2017, closing a stake of 136 shares — an estimated $1.47M sold.

Bank Hapoalim BM first reported a position in RDHL in Q1 2015 and held it in 11 quarters. The position peaked at $2.05M in Q3 2016. 31 funds tracked by Wall St. Rank hold RDHL as of Q4 2017.

  • Bank Hapoalim BM reported no remaining Redhill Biopharma position as of Q4 2017 after selling out during the quarter.
  • Bank Hapoalim BM sold 136 Redhill Biopharma shares in Q4 2017, an estimated $1.47M.
  • Bank Hapoalim BM first reported a position in Redhill Biopharma in Q1 2015 and held it in 11 quarters.
  • Bank Hapoalim BM's Redhill Biopharma position peaked at $2.05M in Q3 2016.
  • 31 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2017.

Based on Bank Hapoalim BM's 13F filing for Q4 2017, filed 5 Feb 2018.